AQUESTIVE THERAPEUTICS

Lobbying client · Indiana · filed 2025 to 2026

pharmaceutical company

$230,000 Reported spend

5 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (68148), not by name.

Firms hired 1

BRACEWELL LLP $230,000 5 filings

Bills named in these filings 2

HR 1262
Mikaela Naylon Give Kids a Chance Act

3 filings
S 932
Give Kids a Chance Act of 2025

3 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $110,000 3 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 7

Consumer Product Safety Commission (CPSC) 4
SENATE 4
HOUSE OF REPRESENTATIVES 3
Food & Drug Administration (FDA) 1
Health & Human Services, Dept of (HHS) 1
Office of Management & Budget (OMB) 1
White House Office 1

Recent filings 5 total

Q2

BRACEWELL LLP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 16, 2026

View → Q1

BRACEWELL LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 17, 2026

View → Q4

BRACEWELL LLP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 20, 2026

View → Q3

BRACEWELL LLP

3rd Quarter (July 1 - Sep 30) 2025 · Senate · $50,000 income · posted Oct 20, 2025

View → RR

BRACEWELL LLP

3rd Quarter (July 1 - Sep 30) 2025 · posted Jul 22, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.